Fresenius Medical Care

Fresenius Medical Care

A healthcare company that provides dialysis treatment for those with chronic kidney diseases.

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2020202120222023202420252026
Revenues17.9b17.6b19.4b19.5b19.4b20.1b20.9b
% growth2 %(1 %)10 %--3 %4 %
EBITDA2.3b1.9b1.6b3.4b3.3b3.7b3.9b
% EBITDA margin13 %11 %8 %18 %17 %18 %19 %
Profit1.2b969m673m499m648m934m1.1b
% profit margin7 %5 %3 %3 %3 %5 %5 %
EV / revenue1.8x1.6x1.1x1.1x1.0x1.0x0.9x
EV / EBITDA13.5x14.8x13.2x6.4x6.0x5.3x4.7x
R&D budget194m221m229m232m---
R&D % of revenue1 %1 %1 %1 %---
  • Edit
DateInvestorsAmountRound
*
N/A

€1.3b

Post IPO Debt
N/A

€1.5b

Post IPO Debt
*

N/A

-
*

$318k

Post IPO Equity
*

$209k

Post IPO Equity
Total Funding-

Recent News about Fresenius Medical Care

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit

Investments by Fresenius Medical Care

Edit
Renal Advantage
ACQUISITION by Fresenius Medical Care Aug 2011
ApolloMed
exited
NxStage Medical
ACQUISITION by Fresenius Medical Care Aug 2017
Humacyte
exited
Xenios AG
ACQUISITION by Fresenius Medical Care Nov 2016
Corvidia
ACQUISITION by Novo Nordisk Jun 2020
Renal Solutions
ACQUISITION by Fresenius Medical Care Nov 2007
View 4 more